Skip to main content

Advertisement

SpringerLink
Log in

Increased expression of IL-28RA mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune and inflammatory disease with a strong genetic contribution and characterized by kinds of immune reactions. Our previous genome-wide association studies have identified IL-28RA as a susceptibility gene for SLE. In this study, we performed a quantitative reverse transcription polymerase chain reaction (RT-PCR) in 62 patients with SLE and 69 controls to investigate the different expression levels of IL-28RA in peripheral blood mononuclear cells (PBMCs) from SLE patients and healthy controls and the association between IL-28RA expression and systemic lupus erythematosus disease activity index (SLEDAI) or the variant of the single-nucleotide polymorphism (SNP) rs4649203. The expression levels of IL-28RA messenger RNA (mRNA) in SLE patients were significantly increased compared with those of healthy controls. In addition, there were also significant differences in the expression levels of IL-28RA between active (SLEDAI ≥ 6) or inactive (SLEDAI < 6) SLE groups and healthy controls. However, no correlation was observed between IL-28RA mRNA expression level and SLEDAI. There was no association between the variant of the SNP rs4649203 and IL-28RA mRNA expression levels neither. These results indicated that expression of IL-28RA mRNA may be correlated with the pathogenesis of SLE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Wong CK, Ho CY, Li EK, Lam CW (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9(8):589–593

    Article  CAS  PubMed  Google Scholar 

  2. Li Y, Cheng H, Zuo XB, Sheng YJ, Zhou FS, Tang XF, Tang HY, Gao JP, Zhang Z, He SM, Lv YM, Zhu KJ, Hu DY, Liang B, Zhu J, Zheng XD, Sun LD, Yang S, Cui Y, Liu JJ, Zhang XJ (2013) Association analyses identifying two common susceptibility loci shared by psoriasis and systemic lupus erythematosus in the Chinese Han population. J Med Genet 50(12):812–818. doi:10.1136/jmedgenet-2013-101787

    Article  CAS  PubMed  Google Scholar 

  3. Dumoutier L, Lejeune D, Hor S, Fickenscher H, Renauld JC (2003) Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3. Biochem J 370(Pt 2):391–396. doi:10.1042/BJ20021935

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4(1):69–77. doi:10.1038/ni875

    Article  CAS  PubMed  Google Scholar 

  5. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4(1):63–68. doi:10.1038/ni873

    Article  CAS  PubMed  Google Scholar 

  6. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. doi:10.1002/1529-0131(199709)40:9<1725::AID-ART29>3.0.CO;2-Y

    Article  CAS  PubMed  Google Scholar 

  7. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630–640

    Article  CAS  PubMed  Google Scholar 

  8. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25(4):402–408. doi:10.1006/meth.2001.1262

    Article  CAS  PubMed  Google Scholar 

  9. Mok CC, Lau CS (2003) Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56(7):481–490

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Dumoutier L, Tounsi A, Michiels T, Sommereyns C, Kotenko SV, Renauld JC (2004) Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem 279(31):32269–32274. doi:10.1074/jbc.M404789200

    Article  CAS  PubMed  Google Scholar 

  11. Cui Y, Sheng Y, Zhang X (2013) Genetic susceptibility to SLE: recent progress from GWAS. J Autoimmun 41:25–33. doi:10.1016/j.jaut.2013.01.008

    Article  CAS  PubMed  Google Scholar 

  12. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR (2008) An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 180(4):2474–2485

    Article  CAS  PubMed  Google Scholar 

  13. Cao Y, Zhang R, Zhang W, Zhu C, Yu Y, Song Y, Wang Q, Bai L, Liu Y, Wu K, Wu J (2014) IL-27, a cytokine, and IFN-lambda1, a type III IFN, are coordinated to regulate virus replication through type I IFN. J Immunol 192(2):691–703. doi:10.4049/jimmunol.1300252

    Article  CAS  PubMed  Google Scholar 

  14. Ding S, Khoury-Hanold W, Iwasaki A, Robek MD (2014) Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth. PLoS Biol 12(1):e1001758. doi:10.1371/journal.pbio.1001758

    Article  PubMed Central  PubMed  Google Scholar 

  15. O’Connor KS, Ahlenstiel G, Suppiah V, Schibeci S, Ong A, Leung R, van der Poorten D, Douglas MW, Weltman MD, Stewart GJ, Liddle C, George J, Booth DR (2013) IFNL3 mediates interaction between innate immune cells: implications for hepatitis C virus pathogenesis. Innate Immun 20(6):598–605

    Article  PubMed  Google Scholar 

  16. Tezuka Y, Endo S, Matsui A, Sato A, Saito K, Semba K, Takahashi M, Murakami T (2012) Potential anti-tumor effect of IFN-lambda2 (IL-28A) against human lung cancer cells. Lung Cancer 78(3):185–192. doi:10.1016/j.lungcan.2012.09.005

    Article  PubMed  Google Scholar 

  17. Maher SG, Sheikh F, Scarzello AJ, Romero-Weaver AL, Baker DP, Donnelly RP, Gamero AM (2008) IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol Ther 7(7):1109–1115

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Silverman RH, Williams BR (2001) Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69(6):912–920

    PubMed  Google Scholar 

  19. Fensterl V, Sen GC (2009) Interferons and viral infections. Biofactors 35(1):14–20. doi:10.1002/biof.6

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank all the study participants and all the volunteers who have so willingly participated in this study, thus making this study possible. This work was supported by grants from the National Key Basic Research Program of China (2014CB541901, 2012CB722404, and 2011CB512103), the Research Project of Chinese Ministry of Education (No. 213018A) and the Program for New Century Excellent Talents in University (NCET-12-0600), the National Natural Science Foundation of China (81402590, 81371722, 81320108016, and 81171505), the Natural Science Fund of Anhui province (1408085MKL27) and the Youth Science Training Program of National Natural Science Foundation of China (2010kj10).

Disclosures

None.

Author information

Author notes

    Authors and Affiliations

    1. Institute of Dermatology and Department of Dermatology, The First Affiliated Hospital, Anhui Medical University, Meishan Road, Hefei, 230032, Anhui, China

      Yu-Yan Cheng, Yu-Jun Sheng, Yan Chang, Yan Lin, Zheng-Wei Zhu, Lei-Lei Wen, Chao Yang, Lu Liu, Lu-Lu Yang, Fu-Sheng Zhou, Xiao-Dong Zheng, Xian-Yong Yin, Sheng-Quan Zhang, Sen Yang & Xue-Jun Zhang

    2. Department of Dermatology, China-Japan Friendship Hospital, Beijing, 100029, China

      Yong Cui

    Authors
    1. Yu-Yan Cheng
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Yu-Jun Sheng
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Yan Chang
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Yan Lin
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Zheng-Wei Zhu
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Lei-Lei Wen
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Chao Yang
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Lu Liu
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Lu-Lu Yang
      View author publications

      You can also search for this author in PubMed Google Scholar

    10. Fu-Sheng Zhou
      View author publications

      You can also search for this author in PubMed Google Scholar

    11. Xiao-Dong Zheng
      View author publications

      You can also search for this author in PubMed Google Scholar

    12. Xian-Yong Yin
      View author publications

      You can also search for this author in PubMed Google Scholar

    13. Sheng-Quan Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    14. Yong Cui
      View author publications

      You can also search for this author in PubMed Google Scholar

    15. Sen Yang
      View author publications

      You can also search for this author in PubMed Google Scholar

    16. Xue-Jun Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding authors

    Correspondence to Yong Cui or Sen Yang.

    Additional information

    Yu-Yan Cheng, Yu-Jun Sheng and Yan Chang contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Cheng, YY., Sheng, YJ., Chang, Y. et al. Increased expression of IL-28RA mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Rheumatol 34, 1807–1811 (2015). https://doi.org/10.1007/s10067-015-2947-5

    Download citation

    • Received:

    • Revised:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s10067-015-2947-5

    Keywords

    Search

    Navigation